Immix Biopharma Inc
$ 11.34
3.37%
17 Aug - close price
- Market Cap 917,849,000 USD
- Current Price $ 11.34
- High / Low $ 11.53 / 10.74
- Stock P/E N/A
- Book Value 3.20
- EPS -0.91
- Next Earning Report 2026-11-06
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.20 %
- ROE -0.34 %
- 52 Week High 15.10
- 52 Week Low 1.99
About
Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, is dedicated to the development of various tissue-specific therapies in oncology and inflammation in the United States and Australia. The company is headquartered in Los Angeles, California.
Analyst Target Price
$22.52
Quarterly Earnings
| Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-08-07 | 2026-05-07 | 2026-03-25 | 2025-11-07 | 2025-08-08 | 2025-05-08 | 2025-03-24 | 2024-11-12 | 2024-08-12 | 2024-05-09 | 2024-03-29 | 2023-11-09 |
| Reported EPS | -0.18 | -0.18 | -0.28 | -0.24 | -0.22 | -0.15 | -0.25 | -0.24 | -0.15 | -0.22 | -0.23 | -0.23 |
| Estimated EPS | -0.17 | -0.21 | -0.15 | -0.19 | -0.16 | -0.23 | -0.25 | -0.16 | -0.21 | -0.23 | -0.23 | -0.23 |
| Surprise | -0.01 | 0.03 | -0.13 | -0.05 | -0.06 | 0.08 | 0 | -0.08 | 0.06 | 0.01 | 0 | 0 |
| Surprise Percentage | -5.8824% | 14.2857% | -86.6667% | -26.3158% | -37.5% | 34.7826% | 0% | -50% | 28.5714% | 4.3478% | 0% | 0% |
Next Quarterly Earnings
| Sep 2026 | |
|---|---|
| Reported Date | 2026-11-06 |
| Fiscal Date Ending | 2026-09-30 |
| Estimated EPS | -0.18 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
